| Patent | Date |
|---|
1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity
Grant 8,975,256 - Matsuda , et al. March 10, 2 | 2015-03-10 |
Method for treating an inflammatory disease by administering a 1,2,3,4- tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituent
Grant 8,664,221 - Kato , et al. March 4, 2 | 2014-03-04 |
Method For Treating An Inflammatory Disease By Administering A 1,2,3,4-tetrahydroquinoxaline Compound Containing A Phenyl Group Having A Sulfonic Acid Ester Structure Introduced Therein As A Substituent
App 20140045842 - KATO; Masatomo ; et al. | 2014-02-13 |
1,2,3,4-tetrahydroquinoxaline Compounds Having Glucocorticoid Receptor Binding Activity
App 20130303537 - MATSUDA; Mamoru ; et al. | 2013-11-14 |
Method for treating a disease related to the glucocorticoid receptor
Grant 8,580,784 - Matsuda , et al. November 12, 2 | 2013-11-12 |
Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound
Grant 8,569,493 - Matsuda , et al. October 29, 2 | 2013-10-29 |
Method for preventing or treating a disease related to the glucocorticoid receptor
Grant 8,563,551 - Matsuda , et al. October 22, 2 | 2013-10-22 |
1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
Grant 8,551,991 - Matsuda , et al. October 8, 2 | 2013-10-08 |
Method for treating a disease related to the glucocorticoid receptor
Grant 8,440,660 - Matsuda , et al. May 14, 2 | 2013-05-14 |
Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group
Grant 8,426,406 - Kato , et al. April 23, 2 | 2013-04-23 |
Method for preventing or treating a glucocorticoid receptor-related disease
Grant 8,420,635 - Matsuda , et al. April 16, 2 | 2013-04-16 |
1,2,3,4-tetrahydroquinoxaline compound with a phenyl group substituent having a sulfonic acid ester structure or a sulfonic acid amide structure introduced therein and having glucocorticoid receptor-binding activity
Grant 8,193,187 - Matsuda , et al. June 5, 2 | 2012-06-05 |
Methods For Preventing Or Treating Metabolic Diseases, Inflammatory Diseases, Autoimmune Diseases, Allergic Diseases, Central Nervous System Diseases, Cardiovascular Diseases, Homeostasis-related Diseases Or Glaucoma
App 20120129866 - Matsuda; Mamoru ; et al. | 2012-05-24 |
Method for preventing or treating a disease related to the glucocorticoid receptor
App 20110275620 - Matsuda; Mamoru ; et al. | 2011-11-10 |
Method for preventing or treating a disease related to the glucocorticoid receptor
App 20110275632 - MATSUDA; Mamoru ; et al. | 2011-11-10 |
Method for preventing or treating a glucocorticoid receptor-related disease
App 20110263589 - Matsuda; Mamoru ; et al. | 2011-10-27 |
Method for preventing or treating a disease related to the glucocorticoid receptor
App 20110263600 - Matsuda; Mamoru ; et al. | 2011-10-27 |
1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
Grant 8,017,775 - Matsuda , et al. September 13, 2 | 2011-09-13 |
1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents
Grant 8,008,496 - Matsuda , et al. August 30, 2 | 2011-08-30 |
1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
Grant 8,008,497 - Matsuda , et al. August 30, 2 | 2011-08-30 |
1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
Grant 8,008,498 - Matsuda , et al. August 30, 2 | 2011-08-30 |
Glucocorticoid Receptor Agonist Comprising 1,2,3,4-tetrahydroquinoxaline Derivatives Containing Phenyl Group Having Sulfonic Acid Ester Structure Introduced Therein As Substituent
App 20110166151 - Kato; Masatomo ; et al. | 2011-07-07 |
Glucocorticoid Receptor Agonist Comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline Derivatives Having Substituted Oxy Group
App 20110118260 - Kato; Masatomo ; et al. | 2011-05-19 |
Novel 1,2,3,4,-tetrahydroquinoxaline Derivative Which Has, As Substituent, Phenyl Group Having Sulfonic Acid Ester Structure Or Sulfonic Acid Amide Structure Introduced Terein And Has Glucocorticoid Receptor-binding Activity
App 20100137307 - Matsuda; Mamoru ; et al. | 2010-06-03 |
Novel 1,2-dihydroquinoline Derivative Having Substituted Phenylchalcogeno Lower Alkyl Group And Ester- Introduced Phenyl Group As Substituents
App 20100056504 - Matsuda; Mamoru ; et al. | 2010-03-04 |
Novel 1-2-Dihydroquinoline Derivative Having Glucocorticoid Receptor Binding Activity
App 20090326009 - Matsuda; Mamoru ; et al. | 2009-12-31 |
Novel 1,2-dihydroquinoline Derivative Having Substituted Phenylamino Lower Alkyl Group And Ester-introduced Phenyl Group As Substituents
App 20090298827 - Matsuda; Mamoru ; et al. | 2009-12-03 |
Novel 1,2-dihydroquinoline Derivative Having (substituted Phenyl Or Substituted Heterocyclic) Carbonyloxy Lower Alkyl Group And Ester-introduced Phenyl Group As Substituents
App 20090298826 - Matsuda; Mamoru ; et al. | 2009-12-03 |
Novel 1,2,3,4-Tetrahydroquinoxaline Derivative Having Glucocorticoid Receptor Binding Activity
App 20090111807 - Matsuda; Mamoru ; et al. | 2009-04-30 |
Therapeutic agent for rheumatic disease comprising benzamide derivative as active ingredient
App 20050215601 - Aono, Hiroyuki ; et al. | 2005-09-29 |
| 